Plain-English translation of NCT06613841 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Glioblastoma research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing whether advanced imaging scans—including PET scans using a tracer called 18F-Fluciclovine and a special high-powered MRI machine—can help doctors better understand how glioblastoma tumors grow and change. The goal is to gather information that might help improve how doctors diagnose and monitor this aggressive brain cancer in the future.
Glioblastoma is a serious brain cancer that can come back after treatment, and doctors currently have limited ways to tell if a tumor is growing or if a patient is responding to treatment. This study is exploring whether these advanced imaging techniques can reveal important information about tumor behavior that standard scans might miss.
You likely qualify if…
You likely don't qualify if…
You would come in for two imaging sessions (which can be done on the same day or up to 7 business days apart, whichever is more convenient). In each session, you'll receive an injection of a safe radioactive tracer and then spend about 45 minutes in a PET/CT scanner, take a one-hour break, and then have another 20-minute scan. You'll also be invited to undergo an optional 60-minute MRI scan on a specialized 7-Tesla machine. The imaging results will help researchers learn more about your tumor, but they won't be used to change your treatment plan.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States